Literature DB >> 2241285

Juvenile psoriatic arthritis and HLA antigens.

M L Hamilton1, D D Gladman, A Shore, R M Laxer, E D Silverman.   

Abstract

The clinical, laboratory, and radiological features, including histocompatibility typing, of 28 patients with juvenile psoriatic arthritis are reported. The most common presentation was that of psoriasis preceding or occurring simultaneously with arthritis. The most common course of juvenile psoriatic arthritis was to start as an oligoarthritis and progress, usually to polyarthritis. No patients with juvenile psoriatic arthritis had uveitis. Overall, most patients had a good outcome (93% in functional class I and II), though 8/28 (29%) did require disease modifying drugs over a mean period of 8.8 years of follow up. The clinical features of these patients were very similar to those of a group of 158 adult patients with psoriatic arthritis with the same disease duration followed up in the clinic. Although there was an increased prevalence of B17 in both juvenile and adult psoriatic arthritis, juvenile psoriatic arthritis showed increased prevalence of A2, whereas adult psoriatic arthritis showed increased prevalence of B27, Bw39, and Cw6. This HLA association differed from that reported in other forms of juvenile arthritis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2241285      PMCID: PMC1004206          DOI: 10.1136/ard.49.9.694

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

1.  Diagnosis of "probable" Still's disease and its outcome.

Authors:  B M ANSELL; E G BYWATERS
Journal:  Ann Rheum Dis       Date:  1962-09       Impact factor: 19.103

2.  The prospect of psoriasis.

Authors:  R CHURCH
Journal:  Br J Dermatol       Date:  1958-04       Impact factor: 9.302

3.  Epidemiological aspects of psoriasis and arthritis.

Authors:  H Baker
Journal:  Br J Dermatol       Date:  1966-05       Impact factor: 9.302

4.  Juvenile psoriatic arthritis--an analysis of 60 cases.

Authors:  A Shore; B M Ansell
Journal:  J Pediatr       Date:  1982-04       Impact factor: 4.406

5.  Psoriatic arthritis (PSA)--an analysis of 220 patients.

Authors:  D D Gladman; R Shuckett; M L Russell; J C Thorne; R K Schachter
Journal:  Q J Med       Date:  1987-02

6.  HLA antigens in psoriatic arthritis.

Authors:  D D Gladman; K A Anhorn; R K Schachter; H Mervart
Journal:  J Rheumatol       Date:  1986-06       Impact factor: 4.666

7.  Frequency of HLA antigens in patients with psoriasis or psoriatic arthritis.

Authors:  R J McKendry; D P Sengar; J P DesGroseilliers; J V Dunne
Journal:  Can Med Assoc J       Date:  1984-02-15       Impact factor: 8.262

8.  Psoriatic arthritis in childhood.

Authors:  E M Sills
Journal:  Johns Hopkins Med J       Date:  1980-02

9.  Immunogenetics of juvenile chronic arthritis.

Authors:  E Albert; B M Ansell
Journal:  Scand J Rheumatol Suppl       Date:  1987

10.  Psoriatic arthritis in children.

Authors:  T R Southwood; R E Petty; P N Malleson; E A Delgado; D W Hunt; B Wood; M L Schroeder
Journal:  Arthritis Rheum       Date:  1989-08
View more
  5 in total

Review 1.  Juvenile onset spondyloarthropathies: therapeutic aspects.

Authors:  R Burgos-Vargas
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

Review 2.  Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors.

Authors:  P J Mease
Journal:  Ann Rheum Dis       Date:  2002-04       Impact factor: 19.103

Review 3.  Immunogenetics of juvenile idiopathic arthritis: A comprehensive review.

Authors:  Aimee O Hersh; Sampath Prahalad
Journal:  J Autoimmun       Date:  2015-08-21       Impact factor: 7.094

Review 4.  Prognostic factors in juvenile idiopathic arthritis.

Authors:  A M Prieur; G Chèdeville
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.686

5.  Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis?

Authors:  Yonatan Butbul Aviel; Pascal Tyrrell; Rayfel Schneider; Sandeep Dhillon; Brian M Feldman; Ronald Laxer; Rotraud K Saurenmann; Lynn Spiegel; Bonnie Cameron; Shirley Ml Tse; Earl Silverman
Journal:  Pediatr Rheumatol Online J       Date:  2013-03-15       Impact factor: 3.054

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.